These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12606730)

  • 1. Inappropriate advertising of dietary supplements.
    Drazen JM
    N Engl J Med; 2003 Feb; 348(9):777-8. PubMed ID: 12606730
    [No Abstract]   [Full Text] [Related]  

  • 2. Illegal human growth hormone markets. Issues in controlling online drug sales and advertising.
    Taylor E
    J Leg Med; 2008; 29(2):237-53. PubMed ID: 18569443
    [No Abstract]   [Full Text] [Related]  

  • 3. Can growth hormone prevent aging?
    Vance ML
    N Engl J Med; 2003 Feb; 348(9):779-80. PubMed ID: 12606731
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for the promotion of dietary supplements: examining government regulation five years after enactment of the Dietary Supplement Health and Education Act of 1994.
    Pinco RG; Halpern TH
    Food Drug Law J; 1999; 54(4):567-86. PubMed ID: 11824454
    [No Abstract]   [Full Text] [Related]  

  • 5. [Growth hormone therapy is useful even for adults].
    Viikari J; Välimäki M; Salmi J; Salmela P; Kataja M; Turunen H; Soppi E
    Duodecim; 1998; 114(9):867-77. PubMed ID: 11524806
    [No Abstract]   [Full Text] [Related]  

  • 6. Inappropriate advertising of dietary supplements.
    Taylor H
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12773657
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study.
    Major GC; Doucet E; Jacqmain M; St-Onge M; Bouchard C; Tremblay A
    Br J Nutr; 2008 May; 99(5):1157-67. PubMed ID: 17977472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function.
    Gillberg P; Bramnert M; Thorén M; Werner S; Johannsson G
    Growth Horm IGF Res; 2001 Oct; 11(5):273-81. PubMed ID: 11735245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Federal Trade Commission's regulation of advertising claims for dietary supplements.
    Peeler CL; Cohn S
    Food Drug Law J; 1995; 50(3):349-55. PubMed ID: 10343004
    [No Abstract]   [Full Text] [Related]  

  • 13. Is final height the only target of paediatric human growth hormone treatment?
    Clayton PE
    Int J Clin Pract Suppl; 2002 May; (126):3-7. PubMed ID: 12090698
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intrauterine treatment of growth retardation].
    Díez JJ
    Med Clin (Barc); 1999 May; 112(16):616-8. PubMed ID: 10374177
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone research and therapy.
    Grunfield C; Papadakis M
    Science; 1997 Jan; 275(5299):465. PubMed ID: 9019805
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
    Ritzén EM; Lindgren AC; Hagenäs L; Marcus C; Müller J; Blichfeldt S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of advertising claims for multivitamin preparation Vitacor 20/90 on the internet.
    Tröger U; Meyer FP
    BMJ; 1998 Oct; 317(7165):1069-71. PubMed ID: 9774300
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatments for wasting in patients with the acquired immunodeficiency syndrome.
    Corcoran C; Grinspoon S
    N Engl J Med; 1999 Jun; 340(22):1740-50. PubMed ID: 10352167
    [No Abstract]   [Full Text] [Related]  

  • 19. Advertising by pharmaceutical companies in eBMJ. The issue should be debated properly.
    McKechnie S
    BMJ; 1999 Feb; 318(7183):598-9. PubMed ID: 10037648
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.